CD36 and neoplasm: This metabolic adaptability allows tumor cells to maintain proliferative advantages under microenvironmental nutrient fluctuations: DNL supplies raw materials for membrane phospholipid synthesis, while CD36-mediated lipid influx is transported via fatty acid binding protein 1(FABP1) to mitochondrial β-oxidation, sustaining ATP production and tumor growth [10].